Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Fallopian Tube Neoplasms × Epirubicin × 30 days × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 1 Resectable HER2-positive Breast Cancer 1 Non-Muscle Invasive Bladder Neoplasms 1 Breast Neoplasms 1

Interventions

Bevacizumab 12 olaparib 11 Carboplatin 11 Paclitaxel 10 Specimen Handling 9 Magnetic Resonance Spectroscopy 9 liposomal doxorubicin 5 Taxes 5 Gemcitabine 5 Biopsy 5 cediranib 4 Doxorubicin 4 pembrolizumab 3 niraparib 3 Immunoglobulin G 3 Drug Therapy 3 Disulfides 3 mirvetuximab soravtansine 2 Platinum 2 Docetaxel 2 Cisplatin 2 130-nm albumin-bound paclitaxel 2 tremelimumab 1 trastuzumab deruxtecan 1 taxane 1 talazoparib 1 sotorasib 1 rucaparib 1 pelcitoclax 1 palbociclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡